NASDAQ:ZYXI Zynex (ZYXI) Stock Price, News & Analysis $0.12 0.00 (0.00%) As of 10/23/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesNews and TrendsOwnershipSEC Filings About Zynex Stock (NASDAQ:ZYXI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Zynex alerts:Sign Up Key Stats Today's Range$0.13▼$0.1350-Day Range$0.13▼$0.1352-Week Range$0.12▼$2.82VolumeN/AAverage Volume2.32 million shsMarket Capitalization$3.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Zynex, Inc. is a medical technology company that develops and markets noninvasive devices intended to support pain management, rehabilitation and treatment for certain chronic conditions. Its products use electrical stimulation and related technologies to help manage pain, improve muscle function and support physical rehabilitation. The company’s product portfolio includes the NexWave device, which provides transcutaneous electrical nerve stimulation and neuromuscular electrical stimulation; NeuroMove, a rehabilitation system designed to help patients improve muscle activation and movement; and JetStream, a system used for compression therapy. Zynex also offers blood-volume and fluid-management monitoring technology through its Zynex Monitoring business. Founded in 1996, Zynex is headquartered in Englewood, Colorado. The company primarily serves the United States through a physician-prescribed, direct-to-patient business model, with products generally distributed through healthcare providers and reimbursement channels. Thomas Sandgaard is the company’s founder and chief executive officer.AI Generated. May Contain Errors. Read More Receive ZYXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZYXI Stock News HeadlinesKuehn Law Encourages Investors of Zynex, Inc. to Contact Law FirmJuly 21, 2026 | prnewswire.comKuehn Law Encourages Investors of Zynex, Inc. to Contact Law FirmJuly 13, 2026 | globenewswire.comWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7. | Porter & Company (Ad)ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.April 16, 2026 | globenewswire.comZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff DeadlineApril 13, 2026 | globenewswire.comLevi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ZYXIQApril 13, 2026 | globenewswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)April 10, 2026 | globenewswire.comZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit — The Gross Law FirmApril 10, 2026 | globenewswire.comSee More Headlines ZYXI Stock Analysis - Frequently Asked Questions How have ZYXI shares performed this year? Zynex's stock was trading at $0.1260 on January 1st, 2026. Since then, ZYXI shares have decreased by 0.8% and is now trading at $0.1250. How were Zynex's earnings last quarter? Zynex Inc. (NASDAQ:ZYXI) announced its earnings results on Monday, April, 28th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.09. The company earned $26.58 million during the quarter, compared to analysts' expectations of $30.83 million. Zynex had a negative trailing twelve-month return on equity of 804.30% and a negative net margin of 68.35%. Read the conference call transcript. How do I buy shares of Zynex? Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zynex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zynex investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Salesforce (CRM), Moderna (MRNA), Alibaba Group (BABA), Tesla (TSLA) and Block (XYZ). Company Calendar Last Earnings4/28/2025Today10/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ZYXI's financial health is in the Red zone, according to TradeSmith. ZYXI has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ZYXI CIK846475 Webwww.zynex.com Phone(303) 703-4906FaxN/AEmployees770Year Founded1996Profitability EPS (Trailing Twelve Months)($2.43) Trailing P/E RatioN/A Forward P/E Ratio0.63 P/E GrowthN/ANet Income$2.99 million Net Margins-68.35% Pretax Margin-65.57% Return on Equity-804.30% Return on Assets-36.67% Debt Debt-to-Equity Ratio0.56 Current Ratio0.47 Quick Ratio0.32 Sales & Book Value Annual Sales$108.20 million Price / Sales0.04 Cash Flow$0.25 per share Price / Cash Flow0.51 Book Value$1.12 per share Price / Book0.11Miscellaneous Outstanding Shares30,389,000Free Float15,413,000Market Cap$3.80 million OptionableNo Data Beta0.99 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:ZYXI) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredForget the AI predictions. Look at the incomeAI predictions are everywhere, but Tim Plaehn is focused on something concrete: income. He's found a small ...Investors Alley | SponsoredFinally… options made simpleIan Cooper once believed successful options trading meant endless chart-watching, complex strategies, and big ...TradeWins | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredAsk a 20 Year Trading Pro Your Stock Questions Live for 5Ross Givens, a market analyst with over 20 years on Wall Street, goes live every Monday at 9 AM ET to break do...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
